Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.

Saved in:

Bibliographic Details
Title:	Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.
Authors:	Lindeman, Neal I.¹ nlindeman@partners.org, Cagle, Philip T.², Aisner, Dara L.³, Arcila, Maria E.⁴, Beasley, Mary Beth⁵, Bernicker, Eric H.⁶, Colasacco, Carol⁷, Dacic, Sanja⁸, Hirsch, Fred R.⁹, Kerr, Keith¹⁰, Kwiatkowski, David J.¹¹, Ladanyi, Marc¹², Nowak, Jan A.¹³, Sholl, Lynette¹, Temple-Smolkin, Robyn¹⁴, Solomon, Benjamin¹⁵, Souter, Lesley H., Thunnissen, Erik¹⁶, Ming S. Tsao¹⁷, Ventura, Christina B.⁷
Source:	Archives of Pathology & Laboratory Medicine. Mar2018, Vol. 142 Issue 3, p321-346. 26p. 8 Charts.
Database:	Academic Search Ultimate

Description
ISSN:	00039985
DOI:	10.5858/arpa.2017-0388-CP